Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor

Nuclear Medicine and Biology

Volumn 23, Issue 6, 1996, Pages 753-759

  Karube, Yoshiharu ^a   Katsuno, Kentaro ^a   Takata, Jiro ^a   Matsunaga, Kazuhisa ^a   Haruno, Masatora ^a   Kuroki, Masahide ^a   Arakawa, Fumiko ^a   Matsuoka, Yuji ^a   Kanda, Hidetoshi ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b EIKEN CHEMICAL CO LTD   (Japan)

Author keywords

chimeric antibody; monoclonal antibody; radioimmunoscintigraphy; technetium 99m; tumor imaging

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CHIMERIC ANTIBODY; MONOCLONAL ANTIBODY; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOSCINTIGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NUDE MOUSE; TUMOR XENOGRAFT;

EID: 0030220442     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00067-4     Document Type: Article

References (30)

1. 1. Arakawa F., Haruno M., Kuroki M., Kanda H., Watanabe T., Misumi Y. and Matsuoka Y. (1993) Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen. Hybridoma 12, 365-379.
2. 99mTc labeling protein: p-Carboxyethylphenylglyoxal di (N-methylthiosemicarbazone). Int. J. Nucl. Med. Biol. 12, 425-430.
3. 3. Brechbiel M. W. and Gansow O. A. (1992) Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepentaacetic acids for labeling of monoclonal antibodies with the bismuth-212 α-particle emitter. J. Chem. Soc. Perkin Trans. 1, 1173-1178.
4. 4. Burtin P., Chavanel G. and Hirsch-Marie H. (1973) Characterization of a second normal antigen that cross-reacts with CEA. J. Immunol. 111, 1926-1928.
5. 5. Childs R. L. and Hnatowich D. J. (1985) Optimum conditions for labeing of DTPA-coupled antibodies with technetium-99m. J. Nucl. Med. 26, 293-299.
6. 6. Dykes P. W., Hine K. R., Bradwell A. R., Blackburn J. C., Reeder T. A., Drolc Z. and Booth S. N. (1980) Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen. Br. Med. J. 280, 220-222.
7. 7. Fritzberg A. R., Abrams P. G., Beaumier P. L., Kasina S., Morgan A. C. Jr., Rao T. N., Reno J. M., Sanderson J. A., Srinivasan A., Wilbur D. and Vanderheyden J-L. (1988) Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. 85, 4025-4029.
8. 8. Goldenberg D. M., Kim E. E., DeLand F. H., Bennett S. and Primus F. J. (1980) Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res. 40, 2984-2992.
9. 9. Goldenberg D. M., DeLand F., Kim E., Bennett S. Primus F. J., van Nagell J. R. Jr., Estes N., DeSimone P. and Rayburn P. (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N. Engl. J. Med. 298, 1384-1388.
10. 10. Haruno M., Kuroki M., Arakawa F., Kanda H., Watanabe T. and Matsuoka Y. (1994) In vitro and in vivo characterization of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen. Antibod. Immunol. Radiopharm. 7, 133-148.
11. 11. Hawkins E. B., Pant K. D. and Rhodes B. A. (1990) Resistance of direct Tc-99m-protein bond to transchelation. Antibod. Immunol. Radiopharm. 3, 17-25.
12. 12. Hnatowich D. J., Mardirossian G., Rusckowski M., Fogarasi M., Virzi F. and Winnard P. Jr. (1993) Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties. J. Nucl. Med. 34, 109-119.
13. 13. Kohler G. and Milstein C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
14. 14. Kuroki M., Murakami M., Wakisaka M., Knop-Watorek A. K., Oikawa S., Nakazato H., Kosaki G. and Matsuoka Y. (1992) Epitopes predominantly retained on the carcinoembryonic antigen molecules in plasma of patients with malignant tumors but not on those in plasma of normal individuals. Jpn. J. Cancer Res. 83, 505-514.
15. 15. Kuroki M., Arakawa F., Higuchi H., Matsunaga A., Okamoto N., Takakura K. and Matsuoka Y. (1987) Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system. Jpn. J. Cancer Res. 78, 386-396.
16. 16. Kuroki M., Koga Y. and Matsuoka Y. (1981) Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces. Cancer Res. 41, 713-720.
17. 17. Larson S. M. (1990) Clinical radioimmunodetection, 1978-1988: Overview and suggestions for standardization of clinical trials. Cancer Res. 50, 892-898.
18. 18. Mach J-P., Carrel S., Forni M., Ritschard J., Donath A. and Alberto P. (1980) Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: A critical evaluation. N. Engl. J. Med. 303, 5-10.
19. 19. Mach J-P., Carrel S., Merenda C., Sordat B. and Cerottini J-C. (1974) In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248, 704-706.
20. 20. Mather S. J. and Ellison D. (1990) Reduction-mediated technetium-99m labeling of monoclonal antibodies. J. Nucl. Med. 31, 692-697.
21. 21. Matsuoka Y., Hara M., Takatsu K. and Kitagawa M. (1973) Presence of antigen related to the carcinoembryonic antigen in feces of normal adults. GANN 64, 203-206.
22. 22. Meredith R. F., Khazaeli M. B., Plott W. E., Saleh M. N., Liu T., Allen L. F., Russell C. D., Orr R. A., Colcher D., Schlom J., Shochat D., Wheeler R. H. and LoBuglio A. F. (1992) Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer. J. Nucl. Med. 33, 23-29.
23. 23. Mirzadeh S., Brechbiel M. W., Atcher R. W. and Gansow O. A. (1990) Radiometal labeling of immunoproteins: Covalent linkage of 2-(4-isothiocyanatobenzyl)diethylene-triaminepentaacetic acid ligands to immunoglobulin. Bioconjugate Chem. 1, 59-65.
24. 99mTc-labeling method. Nucl. Med. Biol. 19, 669-677.
25. 99mTc. Nucl. Med. Biol. 18, 667-676.
26. 26. Schwarz A. and Steinstraber A. (1987) A novel approach to Tc-99m-labeled monoclonal antibodies [Abstract]. J. Nucl. Med. 28, 721.
27. 27. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J. and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
28. 28. von Kleist S., Chavanel G. and Burtin P. (1972) Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc. Natl. Acad. Sci. 69, 2492-2494.
29. 29. Williams J. M. and Deegan T. (1971) Processes involved in the binding of technetium-99m to human serum albumin. Int. J. Appl. Radiat. Isot. 22, 767-774.
30. 131I-labeled anti-carcinoembryonic antigen monoclonal antibody fragments in nude mice. Cancer Res. 47, 1691-1694.